Uloric
Drug timelines are a Plus or Pro feature.
19 regulatory and trial events tracked for Uloric, covering 2009-02-13 to 2024-10-02. Get the full timeline:
Most recent: Clinical Trial Update: The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More [Phase 4]